Product‰ | Substance | IS MV (STD) | IS Lit. 15, 16 | IT | |
---|---|---|---|---|---|
negative controls | |||||
Rinsing solutions | 0,9% physiological saline, Ringer solution | 0.0 | (0.0) | ||
Buffered solution | Phosphate-buffered saline | 0.0 | (0.0) | ||
positive controls | |||||
1% SDS | Sodium dodecyl sulfat | 16.9 | (1.5) | ||
solutions | |||||
Dettol™ 1 : 14 | 0.35% chloroxylenol + 0.8% denaturated alcohol | 17.4 | (0.0) | 1 : 500 | |
cutasept™ | 72% isopropanol | 18.2 | (0.8) | 18.0 | 1 : 200 |
Octenisept™ | 0.1% octenidin-2HCl | 14.8 | (5.1) | 14.0 | 1 : 100 |
Betaisodona™ | 10% PVP-I | 5.3 | (1.6) | 1 : 10 | |
Betaisodona™ 1:10 | 1% PVP-I | 1.3 | (0.8) | 2.0 | |
Prontosan™ | 0.1% polyhexanid | 1.6 | (2.7) | ||
Lavanid™ | 0.04% polyhexanid | 0.0 | (0.0) | 0.0 | |
MDT | sterile washings from Lucilia sericata maggots | 0.0 | (0.0) | ||
Ointments, pellets | |||||
Iruxol-n™ | Enzyme filtrations from Clostridium histolyticum | 0.0 | (0.0) | ||
Flammazine™ | 1% silver-sulfadiazine | 1.3 | (2.2) | ||
Betaisodona™ | 10% PVP-I | 15.8 | (2.1) | ||
Repithel™ | 3% lysosomal PVP-I | 4.8 | (2.1) | ||
Iodosorb™ ointment | 1,8% cadexomer-iodine | 8.3 | (3.5) | ||
Iodosorb™ pellets | 1% cadexomer-iodine | 5.7 | (3.5) |